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ABSTRACT
Objectives: The paper aimed to isolate Streptomyces strain having the ability to produce antibacterial metabolites and optimize some environmental 
parameters for excellent antibiotic production.
Methods: Different soil samples were collected from extreme environments of desert regions at Karbala Province, Iraq. Actinomycetes were isolated 
using different media. The primary screening for antibacterial production was accomplished, and the antibacterial activities were tested against 
pathogenic bacteria, including Escherichia coli, Staphylococcus aureus, Streptococcus agalactiae, and Pseudomonas aeruginosa. The most potent strain 
was chosen for optimizing some of environmental parameters to increase the bioactive metabolite production. Different parameters were studied 
such as culture media, temperature, pH, and agitation rate.
Results: About eight Streptomyces strains were isolated from soil samples. All isolates appeared variable levels of antibiotic productions against Gram-
positive and negative pathogenic bacteria, and the best one was Streptomyces sp. LHR 9. The antibacterial metabolite production from Streptomyces 
sp. LHR 9 was affected by various cultural parameters. Glucose soybean meal broth as a fermentation medium at pH 7 yielded the highest antibiotic 
production under the optimal fermentation conditions, including the temperature at 35°C with 200 rpm (revolution/min) agitation rate and 7 days 
incubation period.
Conclusion: The Streptomyces sp. LHR 9 showed antibacterial activity against both Gram-positive and negative pathogenic bacteria. It may consider 
as a potential source of drug production. Further study needs to purification and characterization of antibiotic and analyzes the mechanism for the 
antimicrobial activity of this bioactive compound.
Keywords: Streptomyces, Antibacterial metabolite, Optimization, Environmental condition.
INTRODUCTION
Actinomycetes comprise an extensive and diverse group of Gram-
positive aerobic mycelial bacteria. They are widely distributed group 
in nature, particularly the soil inhabit [1]. They have produced many 
important bioactive substances with high pharmaceutical values and 
approximately two-thirds of antibiotics [2]. Almost 80% of the world’s 
antibiotics are known to produce from actinomycetes, mostly from the 
genera Streptomyces and Micromonospora [3].
According to the World Health Organization, over prescription 
and the continuous use of antibiotics have led to evolved the 
antibiotic resistance in many bacterial pathogens. Recently, the 
drug-resistant pathogenic bacteria have emerged more quickly than 
the rate of discovery of new medicines and antibiotics. Therefore, 
many researchers and the pharmaceutical industries have actively 
worked to find new sources of antibiotic production. The isolation 
of actinomycetes from different extreme habitats and screening for 
novel antibiotic productions are continually [1]. Severe infections 
caused by multi-resistant bacteria to commonly used antibiotics and 
become a major global health-care problem in the 21st century [4]. 
Staphylococcus aureus and other nosocomial infection bacteria, 
that are responsible for different types of infections, have become 
resistant to most classes of antibiotics [5]. Clinicians and public health 
officials have faced hospital-acquired drug-resistant S. aureus and 
Pseudomonas aeruginosa which resist wide spectrum of antibiotics. 
Hence, there is a need to rediscover new drugs active against these 
drug-resistant pathogens.
The majority of the actinomycetes inhabit in soil that are essential 
drug sources remain uncultivable, as a result, inaccessible for novel 
antibiotic discovery. Goodfellow and Haynes reviewed the literature 
on isolation of actinomycetes and suggested that only 10% of the 
actinomycetes are isolated from nature [6]. Most of the antibiotics 
in use today are derivatives of secondary metabolites produced by 
actinomycetes and fungi [7,8]. Actinomycetes can be isolated from 
soil and marine sediments. Although the pharmaceutical industry has 
screened soils for about 50 years, only a small fraction of the surface of 
the globe has sampled, and only a small fraction of actinomycetes taxa 
has been discovered [9,10]. Hence, we need to screen more and more 
actinomycetes from different habitats for antimicrobial sources in the 
hope of getting some actinomycetes strains producing new antibiotics 
that have not been discovered yet and active against multiple drug-
resistant pathogens.
Filamentous soil bacteria belonging to the genus Streptomyces widely 
recognized as industrially relevant microorganisms because of 
their ability to produce many kinds of novel secondary metabolites 
including antibiotics and enzymes [11]. Indeed, different Streptomyces 
species produces about 75% of commercially and medically useful 
antibiotics [12].
Under different conditions, antibiotics production by Streptomyces, 
it is possible to improve or lose altogether, so promoting the growth 
and production of secondary metabolites from Streptomyces can be 
carried out by manipulating the nutritional, chemical, and physical 
parameters of the culturing conditions. The cultural factor optimization 
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plays a remarkable role in the productivity and economics of the 
essential process [13-19]. Hence, our study was aimed to the isolation 
of Streptomyces sp. having the ability to produce antibacterial 




Soil samples (50) were collected from 10 to 15 cm depth of the upper 
surface of the ground in the desert region away from about 3 km from 
Al-Razzaza lake at Karbala Province, Iraq. The samples were placed in 
sterile plastic containers separately, tightly sealed and transported to 
the laboratory.
The collected soil samples were dried in a hot air oven at 60-65°C for 
about three hours for reducing the vegetative bacterial. Subsequently, 
the soil samples which containing spores of actinomycetes were 
transferred to sterile tubes separately and store at 4°C until the 
screening performed.
The starch-casein-nitrate-agar medium was used to isolate of 
actinomycetes. The medium was prepared according to the 
manufacturer company instructions. The pH value of the medium 
was adjusted to 7-7.2 and then sterilized in an autoclave at 121°C for 
15 minutes. The medium was then allowed to cool to around 45-50°C, 
and 1 ml of cycloheximide (50 μg/ml) was added before pouring into 
plates. Then, the medium was poured into the plates with different 
thick to prevent drying during the incubation period.
One gram of dried soil sample was suspended in 9 ml sterile normal 
saline to prepare the spore stock solution. Serial dilutions (10−1-10−4) 
were made from the stock. Four Petri dishes containing isolation 
medium were cultured by transferring 0.1 ml of the spore suspension 
from each dilution and spreading on the surface of agar medium 
using a sterile glass spreader. Then, the plates were incubated at 30°C 
for 5 days. After the incubation period, the plates were examined for 
typical actinomycetes colonies, which had regular round, small, opaque, 
compact, frequently pigmented with white, brown, gray-pink, or other 
colors, the colonies were examined under a light microscope to observe 
their colonial morphology and distinguished from fungi colonies. The 
isolated actinomycetes were recultured in nutrient broth and nutrient 
agar slants and stored at 4°C for further study [20,22].
Test organisms used in the study
Four pathogenic bacteria, including Gram-negative (Escherichia coli 
and P. aeruginosa) and Gram-positive (S. aureus and Streptococcus 
agalactiae), were used as test microorganisms for evaluation the 
antibacterial activity of actinomycetes. All the tested pathogenic bacteria 
were obtained from Laboratory of General Health in Karbala Province.
Primary screening for antibacterial activity
Primary screening of antagonism was performed on Muller Hinton 
agar using the perpendicular streak plate method against four test 
organisms, including Gram-negative (E. coli and P. aeruginosa) and 
Gram-positive pathogenic bacteria (S. aureus and S. agalactiae). The 
medium was prepared according to manufacturer company instructions. 
The actinobacterial isolate was streaked across the surface of the agar 
medium at the middle position of the plate and incubated at 30°C 
for 7 days, in triplicate. After that, the test organisms were streaked 
perpendicularly with actinobacterial growth and the space of 2-3 mm 
between two streaks. Then, the plates were incubated at 37°C for 2 days 
for the test organism growing. After that, the plates were then examined, 
and the presences of the clear zone between the actinobacterial growth 
and test microorganism indicate growth inhibition of test organisms.
Secondary screening for antibacterial activity
Actinomycetes isolates were screened for their ability to produce 
bioactive compounds against test microorganisms using the agar 
diffusion methods.
The antibacterial metabolites were produced from actinomycetes 
isolates using the sterile fermentation broth, which composed from 
(g/100 ml distilled water): 2.5% glucose, 0.5% soybean, 0.5% NaCl, 2% 
K2HPO4, 0.05% MgSO4, and 0.01% CaCO3 at pH 7 [22].
The inoculum was separately prepared by cultivated the actinobacterial 
isolates on starch casein nitrate agar at 30°C for 7 days. Then, the 
liquid media (50 ml media/250-ml Erlenmeyer flask) were incubated 
with two disks (6 mm in diameter) of actinobacterial inoculum and 
incubated at 30°C in a rotary shaker at 150 rpm (revolution per min) 
for 7 days. After that, the culture broth was centrifuged at 8000 rpm at 
4°C for 20 minutes. The aliquot supernatant was filtered using 0.45 μm 
membrane filter (Millipore). The filtrate of each actinobacterial isolate 
was tested as antibacterial metabolite [23].
For antibacterial activity determination, pathogenic bacteria were 
grown overnight in nutrient broth at 37°C for 24 h (O.D=0.5; McFarland 
1×108 CFU/ml). The cultures of test organisms were streaked on Moller 
Hinton agar medium separately. Wells (6 mm in diameter) were made in 
each seeded agar plate, and each well was filled with 60 μl of the aliquot 
supernatant containing the active metabolites [24]. The plates were kept 
at 4°C for 2-4 h for the diffusion of the metabolites. Then, the plates were 
incubated at 37°C for 24 h. After the incubation period, the diameter of 
inhibition zones was measured. Each test was in triplicate, and the activities 
were estimated as the mean of the diameter of the inhibition zone [25,26].
The isolates which exhibited higher production of bioactive compounds 
were rescreened for antimicrobial activity against four pathogenic 
bacteria using the agar well diffusion method. The best active 
actinobacterial isolate was chosen for identification and antimicrobial 
metabolite production.
Optimization of antibiotic production conditions
The optimization of cultural conditions was determined for improving 
the production of antimicrobial metabolites from selected isolate. The 
experiments were performed as batch fermentation.
Fermentation media
The selected isolate was cultured in different types of culture media at 
pH 7 (50 ml media/250-ml Erlenmeyer flask), which composed of the 
following constituents (g/l):
• Glucose-soybean (GS) medium: Glucose 25, soybean 5, NaCl 5, 
K2HPO4 2, MgSO4 0.5, and CaCO3 1 [22].
• Glucose-yeast-meat-peptone (GYMP) in medium: Glucose 10, yeast 
extract 1, meat extract 4, peptone 4, and NaCl 2 [27].
• Glucose-glycerol-soybean (GGS) medium: Glucose 15, glycerol 2.5, 
soybean meal 25, NaCl 2.5, NaNO3 4, K2HPO4 5, ZnSO4 0.04, and 
CaCO3 0.4 [28].
• Starch-yeast-malt-casein-peptone medium (SYMCP): Starch 10, malt 
extract 10, casein 3, peptone 1, yeast extract 1, and K2HPO4 0.5 [29].
• Dextrose-yeast-malt medium: Malt extract 10, dextrose 4, and yeast 
extract 4 [29].
All media were sterilized by autoclave at 121°C for 15 minutes; then, 
they were inoculated with the actinobacterial inoculum (2 disk/50 ml 
medium with 6 mm in diameter) and incubated with shaking incubator 
at 150 rpm (revolutions/minute) and 30°C for 7 days, in triplicate for 
each medium.
Optimization incubation temperature
The optimum temperature for antibiotic production was determined 
using different incubation temperatures ranged from 15°C to 45°C 
with 5°C intervals. The optimum media at pH 7 were inoculated with 
the actinobacterial isolate and incubated with shaking incubator at 
150 rpm for 7 days, in triplicate for each temperature [30].
The initial pH value of production medium
The effect of the initial pH values of production medium was studied, each 
150 ml of optimum liquid medium was adjusted to initial pH values ranged 
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from 5 to 10 using 1N HCl or NaOH, and then it distributed into three flasks 
(50 ml medium/250 ml flask). The media were inoculated with selected 
isolate and incubated at the optimum temperature with shaking incubator 
at 150 rpm for 7 days, in triplicate for each pH value [30].
Agitation rate of production medium
The optimum medium was inoculated with the selected isolate and 
incubated at the optimum temperature with different agitation rates 
ranged from 100 to 350 rpm, in addition to the static condition (0 rpm) 
for 7 days, in triplicate for each agitation rate [31].
Statistical analyses
Data were analyzed using SPSS version 22 software Fisher’s exact with 
a significant value of <0.05.
RESULTS AND DISCUSSION
Actinomycetes isolation and antibiotic screening
From the desert soil samples, 8 actinomycetes isolates were recovered 
and identified depending on microbial, cultural, biochemical, and 
molecular characteristics (unpublished data). These isolates were 
preserved in starch-casein-nitrate-agar slants at 4°C for further analysis.
The antibiotic screening (primary and secondary) was done against 
four pathogenic bacterial strains, including Gram-negative (E. coli and 
P. aeruginosa) and Gram-positive pathogenic bacteria (S. aureus and 
S. agalactiae). The results revealed that all actinobacterial isolates 
appeared the ability to produce antibiotic substances against the test 
microorganisms (Table 1).
All actinobacterial isolates exhibited a broad spectrum of antibacterial 
activity against Gram-positive and negative bacteria. The isolate LHR 
9 followed by the isolates LH 12 and LH 3 which showed the highest 
activity among the others. The LHR 9 isolate showed the highest 
antibacterial activity, according to Fisher’s least significant difference 
(LSD) (LSD=3.565) against tested Gram-negative bacteria. It formed 
inhibition zones were 9.333 1.527 mm and 8.667±1.527 mm for 
E. coli and P. aeruginosa, respectively, whereas the isolate LH 12 gave 
an inhibition zone of 7.667±1.527 mm for E. coli and 6.000±1.000 for 
P. aeruginosa. Furthermore, it had high antibacterial activity against 
tested Gram-positive bacteria. These results were consistent with the 
previous studies [24,32,33] which reported the Gram-positive bacteria 
were more susceptible than Gram-negative bacteria to antibacterial 
substances that produced from actinomycetes. The moderate 
antibacterial activity of actinomycetes secondary metabolites against 
the Gram-negative bacteria could be ascribed to the presence of an 
outer membrane that possesses hydrophilic lipopolysaccharide chains 
and forms an additional barrier for the entry of antibiotic extract into 
the cells [16,24,34,35].
Due to the highest antibacterial activity and the excellent growth 
properties, the isolate LHR 9 a yellowish white-colored actinomycetes 
was chosen for production of an antibacterial metabolite. This strain 
was identified according to morphological, physiological, and molecular 
properties and found it related to Streptomyces sp. [21] (unpublished 
data).
Optimization fermentation parameters of antibiotic production 
from Streptomyces sp.
The antimicrobial metabolite from microorganisms influences by 
different environmental parameters such as fermentation media 
composition, temperature, pH, and agitation rate. The optimizing 
production conditions of any microbial product are a crucial step to 
stimulate overproduction from microorganisms such as actinobacterial 
species. Due to the most secondary metabolites such as antimicrobial 
substances are yielded from different pathways in microbial cells, the 
easiest way to improve the production is optimizing fermentation 
parameters. Logically, if we want to determine the effect of any 
parameter, must be non-changed the others, so all the experiments 
were designed at this trend.
Fermentation media
Preliminary, the best fermentation medium was selected depending 
on the results of antibiotic production from Streptomyces sp., when it 
was grown in five different media (Fig. 1). According to the statistical 
analysis (LSD=3.751), the best production medium was GS medium, 
Fig. 1: Effect of different fermentation media on antimicrobial 
production from Streptomyces sp. LHR 9. *Least significant 
difference=3.751 at a level 0.05; The actinobacterial strain was 
grown in liquid media (pH 7) at 30°C and 150 rpm for 7 days. The 
antibiotic activities were measured according to the agar diffusion 
method using Moller Hinton agar; each well (6 mm in diameter) 
was filled with 60 μl of the aliquot supernatant containing 
actinobacterial metabolites produced from Streptomyces sp. LHR 
9, and the plates were incubated at 37°C for 24 hr
Table 1: Secondary screening of antibiotic production from actinomycetes isolates against pathogenic bacteria
Actinomycetes Inhibition zone diameter (mm)±SD
E. coli P. aeruginosa S. aureus S. agalactiae
LH 3 5.333±1.527 5.666±1.154 12.667±2.516 9.000±1.000
LH 6 5.667±1.154 6.000±1.000 10.333±1.527 6.667±1.154
LH 7 3.667±0.577 4.333±1.527 6.667±2.081 4.000±1.732
LHR 9 9.333±1.527 8.667±1.527 11.333±2.309 10.000±2.000
LH 10 4.000±1.732 4.333±1.527 6.000±1.732 5.333±0.577
LH 11 4.333±1.154 4.000±1.000 6.667±1.527 6.000±2.645
LH 12 7.667±1.527 6.000±1.000 11.000±1.000 8.000±1.000
LH 18 5.000±1.732 4.333±2.309 8.667±1.527 5.667±1.527
*Fisher’s LSD (LSD=3.565) at a level 0.05. All isolates were grown in liquid media (pH 7) at 30°C and 150 rpm for 7 days. The antibiotic activities were measured 
according to the agar diffusion method using Moller Hinton agar; each well (6 mm in diameter) was filled with 60 μl of the aliquot supernatant containing 
actinobacterial metabolites produced from actinomycetes and the plates were incubated at 37°C for 24 hr. E. coli: Escherichia coli, S. aureus: Staphylococcus aureus, S. 
agalactiae: Streptococcus agalactiae, P. aeruginosa: Pseudomonas aeruginosa, SD: Standard deviation, LSD: Least significant difference
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which resulted highest inhibition zones of the test microorganisms, 
E. coli (9.333±1.527 mm), P aeruginosa (8.667±1.527 mm), S. aureus 
(11.667±2.081 mm), and S. agalactiae (10.000±1.000 mm). The medium 
was containing the highest glucose concentration (2.5%) and the 
suitable concentration of soybean meal (0.5%), in addition to essential 
mineral salts. Followed by SYMCP medium which contains more 
complex nutrients such as carbon and nitrogen sources (starch, yeast 
extract, malt, casein, and peptone), but at least concentrations ranged 
between 1% and 0.1%. While the GGS medium appeared little antibiotic 
production, in spite of it contains organic and inorganic carbon and 
nitrogen sources. It contains glucose (1.5%), glycerol (0.25%), soybean 
meal (2.5%), and NaNO3 (0.4%), in addition to other essential mineral 
salts. These results indicate that the Streptomyces sp. LHR 9 was preferred 
high concentration of glucose and low concentration of nitrogen source 
to stimulate its growth and antimicrobial metabolites production, due 
to it adapted to grow in a weak nutrient environment (desert, the local 
of isolation). On the other hand, the composition of production medium 
effects on the level of antimicrobial metabolites production depending 
on the structural components of the antibiotics [24].
In spite of all tested media were supplemented with the necessary 
components such as carbon, energy sources, minerals, and growth 
factors for the microorganism growing. However, it appeared variable 
quantities of antibiotic production; this may be due to the nature 
of the organism and its genetic content [21,34]. Glucose has been 
found to increase the growth of Streptomyces sp. LHR 9 and antibiotic 
production; this result was in agreement with other investigations of 
the researchers who stated that glucose was the excellent carbon source 
for antibiotic production [35,36]. The presence of NaCl in producing 
medium was enhanced microbial growth because it was isolated from 
extreme environments. Furthermore, it induced the release of bound 
antibiotic from the mycelia; these results were in agreement with 
the result of previous studies [24,37] which reported the production 
of the antimicrobial metabolite was increased with the presence of 
high concentration of glucose and sodium chloride. Soybean meal is a 
complex nitrogen source and contains some amino acids such as lysine, 
methionine, threonine, tryptophan, aspartic acid, glutamine, proline, 
alanine, valine, and isoleucine. The presence of tryptophan in soybean 
meal increases antibiotic production up to a certain level [38]. Due to 
the GS medium was the best fermentation medium which stimulates 
highest antibiotic production levels from Streptomyces sp. LHR 9, this 
medium was used to optimize other fermentation conditions.
These results were disagreed with studying of Mukhtar et al. [39] 
which concerned with the production of antitumor antibiotic from 
Streptomyces capoamus in batch fermentation and concluded the 
GYMP medium as the best medium for the production of secondary 
metabolites.
Incubation temperature
Any microorganism has an optimum temperature for growing but 
not always it is optimized for secondary metabolite production. 
Hence, the actinobacterial strain (Streptomyces sp. LHR 9) was grown 
in different incubation temperature to determine the optimum for 
antibiotic production using the optimum medium (GS). The preliminary 
experiments showed that the optimum growth temperature was 30°C. The 
present results revealed that the optimum temperature for the maximum 
antibiotic production was 35°C, which indicated by the increasing of 
inhibition zone of tested pathogenic microorganisms (LSD=5.003). 
The inhibition zones reached to 15.667±2.886 mm, 12.000±3.000 mm, 
19.333±2.081 mm, and 17.000±1.000 mm for E. coli, P. aeruginosa, S. 
aureus, and S. agalactiae, respectively (Fig. 2). Whereas, at 30°C, the 
inhibition zones were 10.000±2.000 mm, 8.000±2.000 mm, 17.333±1.527, 
and 11.000±2.000 mm for E. coli, P. aeruginosa, S. aureus, and S. agalactiae, 
respectively. The isolate produced the antibiotic at a range of temperature 
from 20 to 45 in GS medium at pH 7, agitation 160 rpm for 7 days.
From these results, we can conclude that the optimum temperature 
for the antibacterial metabolite production was 35°C and used this 
degree for antibiotic production in the next experiments. Therefore, 
the strain was strictly mesophilic for secondary metabolite production. 
These results were in agreement with the results of Saha et al. [40] who 
studied the optimum conditions of antimicrobial metabolite production 
from Streptomyces sp. MNK7 and they obtained that the optimum 
temperature of antimicrobial fermentation was 35°C. Furthermore, our 
results are consistent with previous studies of Sekhar et al. [41] and 
Narayana and Vijayalakshmi [42].
Initial pH of production medium
To determine the optimum initial pH value of the fermentation medium 
for maximum antibiotic production; the Streptomyces sp. LHR 9 was 
grown in GS medium at different pH values ranging from 5 to 10 and 
optimum temperature 35°C with agitation rate 150 rpm for 7 days. 
The results revealed that the actinobacterial strain produced the 
antibacterial metabolite in GS medium in the different range of pH 
values (5-10). The maximum production at neutral environment 
pH7 (LSD=4.667); The inhibition zones were 18.333±2.516 mm, 
19.333±3.214 mm, 24.000±1.732 mm, and 20.000±2.000 for E. coli, 
P. aeruginosa, S. aureus, and S. agalactiae, respectively (Fig. 3).
The hydronium ion concentration (pH) of the media affects the activity 
of cellular enzymes, nutrient ionization, and transporting through cell 
membranes, consequently its influence on the bacterial growth rate 
and secondary metabolites biosynthesis. The present results were in 
agreement with previous studies [43,44] which reported the optimum 
for antibiotic production from Streptomyces species; Streptomyces 
hygroscopic was pH 7 or near neutral environments. Another study said 
that the optimum pH for the fermentation of antibiotic, granaticin by 
Streptomyces thermoviolaceus was 6.5-7.0 and the Streptomyces isolate 
failed to grow at acidic pH but grow well at pH 7-8 [45].
Agitation rate
The intensity of the agitation applied during fermentation may have 
an impact on growth rate, antibiotic biosynthesis, metabolism through 
transport of nutrients and enzyme activities, cell damage, morphology, 
and broth viscosity in the case of non-Newtonian rheology. Hence 
that, the actinobacterial strain was grown in optimum GS medium at 
pH 7 and different agitation speeds were applied at 35°C for 7 days 
(Fig. 4). The results appeared Streptomyces sp. LHR 9 had the ability 
to produce antibiotic with various agitation rates (100-350 rpm), and 
Fig. 2: Effect of incubation temperature on antimicrobial 
production from Streptomyces sp. LHR 9. *Least significant 
difference=5.003 at a level 0.05; the actinobacterial strain was 
grown in optimum medium GS at pH 7 and 150 rpm for 7 days 
and incubated at different temperatures. The antibiotic activities 
were measured according to the agar diffusion method using 
Moller Hinton agar; each well (6 mm in diameter) was filled 
with 60 μl of the aliquot supernatant containing actinobacterial 
metabolites produced from actinobacterial strain and the plates 
were incubated at 37°C for 24 hr
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the maximum production (LSD = 4.567) occurred at 200 rpm but not 
in static conditions (0 rpm). That may attribute to the decrease in 
the agitation rate that might reduce the dissolved oxygen level in the 
fermentation broth that could effect on the antimicrobial metabolite 
production [46].
Furthermore, the agitation speed increased consequences gradually, 
increasing the production of antimicrobial metabolites, reaching its 
maximum level. The fermentation media filtrate of Streptomyces sp. 
LHR 9 gave inhibition zones 20.000±2.000 mm, 18.667±2.309 mm, 
26.557±1.527 mm, and 23.333±1.527 mm for E. coli, P. aeruginosa, 
S. aureus, and S. agalactiae, respectively, at agitation speed 200 rpm. 
That may be a result of the aeration level in the culture medium when 
increased lead to sufficient supplies of dissolved oxygen in the culture 
media and the nutrient uptake by bacteria also will be increased. On 
the other hand, as the agitation speed rose to 350 rpm, the activity 
of antimicrobial metabolites produced from Streptomyces sp. LHR 
9 in fermentation media filtrate decreased gradually and reached 
its minimum levels as showed as inhibition zones in Fig. 4. Due to 
increasing the agitation speed tends to increase the amount of dissolved 
oxygen available to the culture that makes depletion for the cell growth 
and antimicrobial compound production [14].
Our results were in agreement with the findings of many researchers 
[16,20,32] how found that the productivity increased by culture 
shaking in comparison with the static culture shaking in comparison 
with the static culture. Due to Streptomycetes are obligate aerobic 
organisms [21], while AL-Zahrani [34] found that the shaking culture 
reduced the productivity of Streptomyces J12. Whereas, other species 
of actinomycetes produced antibiotics under static conditions [18,24].
CONCLUSION
Streptomyces sp. LHR 9 produced vital antimicrobial metabolites 
against Gram-positive and negative bacteria. It may act as a potential 
source of drug production. Further study needs to purification and 
characterization of antibiotic and analyze the mechanism for the 
antimicrobial activity of this bioactive compound.
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